Jpmorgan Chase & CO Treace Medical Concepts, Inc. Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,613,532 shares of TMCI stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,613,532

Previous 1,848,997 12.73%

Holding current value

$4.89 Million

Previous $15.5 Million 30.21%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$5.34 - $7.7 $1.26 Million - $1.81 Million	-235,465 Reduced 12.73%	1,613,532 $10.8 Million
Q1 2025 May 12, 2025	SELL	$7.3 - $10.54 $936,020 - $1.35 Million	-128,222 Reduced 6.48%	1,848,997 $15.5 Million
Q4 2024 Feb 12, 2025	BUY	$4.66 - $8.78 $3.33 Million - $6.28 Million	714,984 Added 56.64%	1,977,219 $14.7 Million
Q3 2024 Dec 26, 2024	BUY	$5.01 - $8.45 $4.32 Million - $7.28 Million	861,689 Added 215.13%	1,262,235 $7.32 Million
Q3 2024 Nov 08, 2024	BUY	$5.01 - $8.45 $4.32 Million - $7.28 Million	861,689 Added 215.13%	1,262,235 $7.32 Million
Q2 2024 Dec 26, 2024	SELL	$4.17 - $12.62 $3.59 Million - $10.9 Million	-861,689 Reduced 68.27%	400,546 $2.66 Million
Q2 2024 Aug 12, 2024	BUY	$4.17 - $12.62 $94,550 - $286,145	22,674 Added 6.0%	400,546 $2.66 Million
Q1 2024 Dec 26, 2024	SELL	$11.48 - $15.86 $10.2 Million - $14 Million	-884,363 Reduced 70.06%	377,872 $4.93 Million
Q1 2024 May 10, 2024	BUY	$11.48 - $15.86 $13,994 - $19,333	1,219 Added 0.32%	377,872 $4.93 Million
Q4 2023 Dec 26, 2024	SELL	$6.03 - $12.88 $5.34 Million - $11.4 Million	-885,582 Reduced 70.16%	376,653 $4.8 Million
Q4 2023 Feb 12, 2024	BUY	$6.03 - $12.88 $169,352 - $361,734	28,085 Added 8.06%	376,653 $4.8 Million
Q3 2023 Nov 14, 2023	SELL	$12.16 - $24.87 $371,427 - $759,654	-30,545 Reduced 8.06%	348,568 $4.57 Million
Q2 2023 Aug 11, 2023	BUY	$23.91 - $27.81 $2.34 Million - $2.72 Million	97,910 Added 34.82%	379,113 $9.7 Million
Q1 2023 May 18, 2023	BUY	$20.23 - $26.22 $914,476 - $1.19 Million	45,204 Added 19.15%	281,203 $7.08 Million
Q1 2023 May 11, 2023	BUY	$20.23 - $26.22 $42,078 - $54,537	2,080 Added 0.89%	235,999 $5.94 Million
Q4 2022 Feb 13, 2023	BUY	$20.54 - $24.67 $94,032 - $112,939	4,578 Added 2.0%	233,919 $5.38 Million
Q3 2022 Nov 14, 2022	BUY	$14.71 - $24.18 $51,352 - $84,412	3,491 Added 1.55%	229,341 $5.06 Million
Q2 2022 Aug 11, 2022	SELL	$12.93 - $20.29 $120,546 - $189,163	-9,323 Reduced 3.96%	225,850 $3.24 Million
Q1 2022 May 11, 2022	SELL	$16.73 - $21.58 $474,027 - $611,447	-28,334 Reduced 10.75%	235,173 $4.45 Million
Q4 2021 Feb 10, 2022	BUY	$15.48 - $26.52 $2.73 Million - $4.68 Million	176,598 Added 203.2%	263,507 $4.91 Million
Q3 2021 Nov 12, 2021	BUY	$24.15 - $30.5 $2.1 Million - $2.65 Million	86,909 New	86,909 $2.34 Million

Others Institutions Holding TMCI

# of Institutions

122

Shares Held

58.9M

Call Options Held

Put Options Held

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $168M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Treace Medical Concepts, Inc. Transaction History